BNP Paribas Financial Markets’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $54 | Hold |
|
|||||
|
2025
Q2 | $39 | Hold |
|
|||||
|
2025
Q1 | $11 | Sell |
|
|||||
|
2024
Q4 | $80 | Sell |
|
|||||
|
2024
Q3 | $229 | Buy |
|
|||||
|
2024
Q2 | $95 | Hold |
|
|||||
|
2024
Q1 | $170 | Hold |
|
|||||
|
2023
Q4 | $121 | Sell |
|
|||||
|
2023
Q3 | $304 | Buy |
|
|||||
|
2023
Q2 | $301 | Buy |
|
|||||
|
2023
Q1 | $26 | Sell |
|
|||||
|
2022
Q4 | $32 | Sell |
|
|||||
|
2022
Q3 | $773 | Sell |
|
|||||
|
2022
Q2 | $35.4K | Buy |
|
|||||
|
2022
Q1 | $14.6K | Sell |
|
|||||
|
2021
Q4 | $58.1K | Buy |
|
|||||
|
2021
Q3 | $59.1K | Buy |
|
|||||
|
2021
Q2 | $13.9K | Sell |
|
|||||
|
2021
Q1 | $131K | Buy |
|
|||||
|
2020
Q4 | $37.1K | Sell |
|
|||||
|
2020
Q3 | $69.3K | Buy |
|
|||||
|
2020
Q2 | $36.2K | Sell |
|
|||||
|
2020
Q1 | $107K | Buy |
|
|||||
|
2019
Q4 | $44.3K | Sell |
|
|||||
|
2019
Q3 | $52.4K | Buy |
|
|||||
|
2019
Q2 | $55.7K | Sell |
|
|||||
|
2019
Q1 | $99.5K | Buy |
|
|||||
|
2018
Q4 | $166 | Sell |
|
|||||
|
2018
Q3 | $22.6K | Hold |
|
|||||
|
2018
Q2 | $27.9K | Sell |
|
|||||
|
2018
Q1 | $174K | Buy |
|
|||||
|
2017
Q4 | $128K | Buy |
|
|||||
|
2017
Q3 | $56.4K | Sell |
|
|||||
|
2017
Q2 | $50.8K | Buy |
|
|||||
|
2017
Q1 | $4.14K | Sell |
|
|||||
|
2016
Q4 | $13.4K | Sell |
|
|||||
|
2016
Q3 | $22.3K | Buy |
|
|||||
|
2016
Q2 | $8.61K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $28.7K | Buy |
|